Beneficient
BENF · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | -$0 | -$0 | -$0 | $0 |
| % Growth | 92% | 5.8% | -203% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | 312.1% | 165.8% | 143.4% | 79.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $2 | $0 | $0 |
| Operating Expenses | $0 | $2 | $0 | $0 |
| Operating Income | -$0 | -$3 | -$0 | -$0 |
| % Margin | 304.4% | 2,677.8% | 241.1% | -46.5% |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$3 | -$0 | -$0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $0 | -$2 | -$0 | -$0 |
| % Margin | -644% | 2,118.8% | 124.8% | -56.9% |
| EPS | 69.77 | -666.53 | 11.72 | -101.36 |
| % Growth | 110.5% | -5,787.1% | 111.6% | – |
| EPS Diluted | 0.065 | -666.53 | 11.72 | -101.36 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$3 | -$0 | -$0 |
| % Margin | 445.6% | 2,665.2% | 223% | -13.5% |